ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for January 2021

Interim Chief Scientific Officer Dr. Giorgio Scagliotti Brings Vast IASLC Knowledge to Role

Joy Curzio
on: January 21, 2021In: Behind the Scenes, WCLC 2020 Archive
Interim Chief Scientific Officer Dr. Giorgio Scagliotti Brings Vast IASLC Knowledge to Role

With a long history in leadership positions at the IASLC, Dr. Scagliotti is fully prepared to help guide the society’s scientific projects through a transition period. Dr. Scagliotti, is professor […] Read more


Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs

Leah Lawrence
on: January 21, 2021In: Behind the Scenes, WCLC 2020 Archive
Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with
            CTCs

Caroline Dive, CBE, PhD, FBPhS, FMedSci, Director of the CRUK Manchester Institute Cancer Biomarker Centre, University of Manchester, has been recognized by the IASLC with the Mary J. Matthews Pathology/Translational […] Read more

Dr. Pan-Chyr Yang Honored by IASLC for Contributions to Lung Cancer Prevention

Leah Lawrence
on: January 21, 2021In: Behind the Scenes, WCLC 2020 Archive
Dr. Pan-Chyr Yang Honored by IASLC for Contributions to Lung Cancer Prevention

Pan-Chyr Yang, MD, PhD, Chair Professor at the National Taiwan University Hospital and Academician of Academia Sinica, Taiwan, will be recognized by the International Association for the Study of Lung […] Read more

Paul A. Bunn, Jr., Scientific Award to Dr. Joan H. Schiller

Lauren Evoy Davis
on: January 21, 2021In: Behind the Scenes, WCLC 2020 Archive
Paul A. Bunn, Jr., Scientific Award to Dr. Joan H. Schiller

Breath is life. We depend so much on our ability to breathe with ease but, for patients with lung cancer, that is no small task. For her entire career, Joan […] Read more

Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming Lung Cancer Clinical Trials

David E. Gerber, MD
+more
on: January 21, 2021In: Clinical Trial Design
Revised U.S. Food and Drug Administration Trial Eligibility Guidance: A Major Step Toward Transforming
            Lung Cancer Clinical Trials

By now, investigators, sponsors, clinicians, and patients are widely aware of the crisis facing cancer clinical trials. With scientific discoveries occurring more rapidly than ever, there is a growing need […] Read more

Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

Christian Rolfo, MD, PhD, MBA, Drhc
+more
on: January 20, 2021In: Evolving Standards of Care
Liquid Biopsy: The Key Weapon for Real-Time Monitoring of Patients With NSCLC 

Tissue still represents the “gold standard” biosource for molecular profiling of lung cancer. However, the use of tissue samples in clinical practice is associated with several technical and biological limitations. […] Read more

Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown

Witold K. Rzyman, MD, PhD
on: January 20, 2021In: Lung Cancer Screening
Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown

Discussions about lung cancer screening in Poland started in 2006, and between 2008 and 2010 four lung cancer screening programs were independently implemented by thoracic surgeons in Szczecin, Gdańsk, Poznań, […] Read more

FDA’s Project Patient Voice Launched to Provide Data on PROs

Leah Lawrence
on: January 20, 2021In: Patient Advocacy
FDA’s Project Patient Voice Launched to Provide Data on PROs

In 2020 the U.S. Food and Drug Administration (FDA) launched Project Patient Voice, an online platform for patients and caregivers along with their health care providers to look at patient-reported […] Read more

Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma 

Sanja Dacic
+more
on: January 20, 2021In: Diagnostic Oncology
Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant
            Pleural Mesothelioma 

Sponsored by EURACAN and the IASLC, a multidisciplinary group comprised of pathologists, oncologists, surgeons, radiologists, and molecular biologists met July 5 and 6, 2018, to critically review the current histologic […] Read more

Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

Connor Miller, MS
+more
on: January 20, 2021In: Tobacco Control & Smoking Cessation
Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

Heated tobacco products (HTPs) are a growing category of novel tobacco products. They typically consist of an electronic heating component and a tobacco insert in the form of a cigarette-like […] Read more

«‹345678›

SEARCH ILCN

Archives

PROVIDER RESOURCES

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

INDUSTRY SUPPORTED


COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

INDUSTRY SUPPORTED

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy